Variant report
Variant | nsv830415 |
---|---|
Chromosome Location | chr5:96597763-96764157 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:96601000-96601800 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr5:96601400-96601800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr5:96601400-96603800 | Enhancers | Adipose Nuclei | Adipose |
4 | chr5:96601800-96602200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr5:96601800-96602200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr5:96601800-96602400 | Weak transcription | Fetal Muscle Leg | muscle |
7 | chr5:96602200-96602400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr5:96602200-96602600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
9 | chr5:96602200-96602800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr5:96602400-96602600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr5:96602400-96602600 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr5:96602600-96602800 | Flanking Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr5:96602800-96603000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr5:96603000-96604200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr5:96603400-96603800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr5:96603400-96603800 | Enhancers | Brain Anterior Caudate | brain |
17 | chr5:96607800-96609200 | ZNF genes & repeats | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr5:96609200-96609600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr5:96612400-96612800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr5:96612400-96612800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
21 | chr5:96632800-96633800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr5:96632800-96633800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
23 | chr5:96633000-96633200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
24 | chr5:96633000-96633800 | Enhancers | NHDF-Ad | bronchial |
25 | chr5:96633200-96633800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
26 | chr5:96633200-96636600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
27 | chr5:96633400-96633800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
28 | chr5:96633400-96633800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
29 | chr5:96636600-96637200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
30 | chr5:96641200-96645400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
31 | chr5:96658400-96661400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
32 | chr5:96659600-96660400 | Enhancers | NHDF-Ad | bronchial |
33 | chr5:96659600-96660800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
34 | chr5:96660200-96660600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
35 | chr5:96666800-96667000 | Flanking Bivalent TSS/Enh | Primary hematopoietic stem cells short term culture | blood |
36 | chr5:96666800-96667000 | ZNF genes & repeats | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
37 | chr5:96671800-96672200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
38 | chr5:96672000-96672200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
39 | chr5:96672200-96672400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
40 | chr5:96675000-96675800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
41 | chr5:96691000-96691200 | Enhancers | GM12878-XiMat | blood |
42 | chr5:96691200-96691800 | Enhancers | Primary B cells from peripheral blood | blood |
43 | chr5:96691200-96692200 | Flanking Active TSS | GM12878-XiMat | blood |
44 | chr5:96692200-96695800 | Active TSS | GM12878-XiMat | blood |
45 | chr5:96693400-96694000 | Enhancers | NHEK | skin |
46 | chr5:96693800-96694000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
47 | chr5:96698200-96699000 | Enhancers | Fetal Lung | lung |
48 | chr5:96698400-96699400 | Enhancers | Primary hematopoietic stem cells | blood |
49 | chr5:96699000-96699400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
50 | chr5:96699000-96700600 | Weak transcription | Fetal Lung | lung |